Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01366495 · ClinicalTrials.gov registry record · NA
A Randomized Controlled Trial of HIV Testing and Linkage to Care at Community Corrections
A NA study, sponsored by Friends Research Institute.
- Completed
- Registry status
- NA
- Development phase
- 797
- Enrollment target
NCT01366495: Completed NA study, sponsored by Friends Research Institute.
NCT01366495 is a NA study that has completed, run by Friends Research Institute. The registered enrollment target is 797 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01366495, a NA study, has completed, sponsored by Friends Research Institute.
- COMPLETED
- Registry status
- NA
- Development phase
- 797 participants
- Enrollment target
Study Summary
The investigators propose to conduct both a randomized trial of HIV testing in community corrections, and a randomized trial of linkage to HIV care for people with HIV recruited through community corrections (probation and parole).
Primary Outcome
Aim 1: To determine the willingness of the community corrections population to undergo HIV testing (Seek). Aim 1a: To compare a strategy of rapid HIV testing on site in community corrections (probation and parole offices) to referral to an off site community HIV testing location with a randomized control study (Test).
Interventions
- BEHAVIORAL Project Bridge
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 797 participants |
| Start Date | 2011-04 |
| Est. Completion | 2016-08 |
| Phase | NA |
What the finished NCT01366495 record still lists
NCT01366495 is an interventional study that assigns participants to a tested intervention. The registered 797 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (43% lower).
The record links to 0 conditions, and to 1 intervention - of which Project Bridge is the first listed.
NCT01366495 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01366495 about?
NCT01366495 is a clinical study titled "A Randomized Controlled Trial of HIV Testing and Linkage to Care at Community Corrections". The investigators propose to conduct both a randomized trial of HIV testing in community corrections, and a randomized trial of linkage to HIV care for people with HIV recruited through community corrections (probation and parole).
What is the current status of trial NCT01366495?
This trial is currently completed. It is a NA study. The enrollment target is 797 participants. The study started on 2011-04. Estimated completion is 2016-08.
What interventions are being tested in trial NCT01366495?
The interventions under investigation include: Project Bridge (BEHAVIORAL).
Who is sponsoring clinical trial NCT01366495?
This trial is sponsored by Friends Research Institute, which has 41 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT01366495's enrollment target sits among peer trials
797 140th of 2000 higher than 1,861 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06051058 · 798 participants · NA
Care Transitions App for Patients With Multiple Chronic Conditions
- NCT05150691 · 796 participants · Phase 1
A Phase 1/2a Study of DB-1303/BNT323 in Advanced/Metastatic Solid Tumors
- NCT06208150 · 795 participants · Phase 3
A Study Comparing Talquetamab Plus Pomalidomide, Talquetamab Plus Teclistamab, and Elotuzumab, Pomalidomide, and Dexamethasone or Pomalidomide, Bortezomib, and Dexamethasone in Participants With Relapsed or Refractory Myeloma Who Have Received an Anti-CD38 Antibody and Lenalidomide
- NCT06724172 · 795 participants · NA
CHIME: Comparing Health Interventions for Maternal Equity
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia